Filing Details
- Accession Number:
- 0001110803-13-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-25 19:58:53
- Reporting Period:
- 2013-01-24
- Filing Date:
- 2013-01-25
- Accepted Time:
- 2013-01-25 19:58:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189130 | T Jay Flatley | 5200 Illumina Way San Diego CA 92122 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-01-24 | 5,000 | $10.49 | 399,357 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-01-24 | 3,600 | $50.79 | 395,757 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-01-24 | 1,400 | $51.24 | 394,357 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-01-24 | 5,000 | $0.00 | 5,000 | $10.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 470,000 | 2006-02-28 | 2016-01-30 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 15,000 | Indirect | by Daughters |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 3,600 shares sold ranging from $50.20 to $51.18 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,400 shares sold ranging from $51.20 to $51.31 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
